Skip to main content
. 2022 May 20;13:898022. doi: 10.3389/fneur.2022.898022

Table 2.

Associated symptoms or signs, ipsilateral to the headache, which were reported by the patients in cluster analysis.

Variables Cluster 1 Cluster 2 p
(n = 81) (n = 122)
Conjunctival injection n (%) 54 (66.67) 57 (46.72) 0.004
Lacrimation n (%) 73 (90.12) 88 (72.13) 0.001
Miosis and/or ptosis n (%) 58 (71.60) 42 (34.43) <0.001
Nasal congestion n (%) 60 (74.07) 51 (41.80) <0.001
Rhinorrhea n (%) 56 (69.14) 34 (27.87) <0.001
Forehead and facial sweating n (%) 28 (34.57) 23 (18.85) 0.012
Agitation n (%) 60 (74.07) 49 (40.16) <0.001
Nausea and/or vomiting during attacks n (%) 33 (40.74) 33 (27.s05) 0.042
Phonophobia during attacks n (%) 18 (22.22) 9 (7.38) 0.002
Vertigo during attacks n (%) 6 (7.41) 6 (4.92) 0.465

n, number of subjects; Bold indicates p < 0.05.